Intelligent Investor

Amcor's neat package

By · 22 Mar 2002
By ·
22 Mar 2002
Upsell Banner

Recommendation

Amcor Plc - AMC
Current price
$13.74 at 16:40 (19 April 2024)

Price at review
$7.84 at (22 March 2002)
All Prices are in AUD ($)
Amcor is a good example of what a long term buy recommendation is all about. Since the prehistoric 'accumulate' days in issue 61/Aug 00 (Accumulate - $5.53) the share price has put on 43%. Add some nice dividends reinvested at a 2.5% discount and there's no doubt that this has been a great performer.

In that time there have been many ups and downs for this global paper and packaging manufacturer. But if you invested in the company rather than traded the stock, you've done well.

Overdone

That's why, when the share price fell by 14% between issue 86/Aug 01 (Long Term Buy - $6.82) and issue 88/Sep 01 (Long Term Buy - $5.89) we said that 'this fall should look overdone in the long-term'. Well, it didn't take long.

Last month Amcor posted its half-year results. Judging by the 12% gain since issue 94/Dec 01 (Long Term Buy - $7.05), the market likes what it sees. The $3.7bn sales figure reveals a global spread that humbles this company's beginnings. Australasia, North America and Europe all contributed about a third of this figure with Asia chipping in 4% of the total.

When it comes to diversification across countries and currencies, Rio Tinto is a very learned role model. Amcor is employing a similar strategy that's so far proving successful.

After pulling off a three-way European merger in April last year in flexible packaging (corrugated boxes and cartons, paper linings, sacks, industrial and food wrappings etc), Amcor came out with 67% ownership and a 15% market share.

That gives it some pricing power. The man responsible for this shake-up in focus and offshore push is MD Russell Jones. He believes a 20% share of the European market isn't so far away.

North American earnings increased 29% thanks mostly to PET (a high-tech plastic bottling substitute) operations, where Amcor recently spent $12m on Pet Pak of Canada.

Consolidation

Further global consolidation in the flexibles business is quite likely, with Amcor playing a key role, as the latest UK acquisition attests. Still, we'd suggest the key to the company's future growth comes from its PET innovations.

In flexibles, as they're known, Amcor plans to increase margins by lifting market share. If it achieves its targeted 15% return on funds employed we'd expect niche competitors to start nipping away at that figure.

The same cannot be said of PET production. Amcor is committed to ongoing research and development to allow it to grow market share at sustainable higher margins. Such products are not so easily copied.

What of the company's production profile? With 61% in food and beverage, 22% in industrial, 9% consumer goods and 8% in tobacco, it has defensive and growth characteristics.

And, with inefficient plants being closed in Europe and lower head counts, the market is very optimistic.

Which brings us to price. With enthusiasm for Jones' efforts pushing the stock towards $8, we've increased our share price risk. With the yield shrinking by the day - currently 3.55% – any stumble will be duly punished.

That, though, does not dishearten us. The benefits of merging and consolidating operations in Europe are yet to have their full effect and Jones' strategy has some way to go before he achieves the group's full potential.

Provided he isn't seduced into paying more for those acquisitions to deliver on his strategy, Amcor should grow stronger. LONG TERM BUY.

IMPORTANT: Intelligent Investor is published by InvestSMART Financial Services Pty Limited AFSL 226435 (Licensee). Information is general financial product advice. You should consider your own personal objectives, financial situation and needs before making any investment decision and review the Product Disclosure Statement. InvestSMART Funds Management Limited (RE) is the responsible entity of various managed investment schemes and is a related party of the Licensee. The RE may own, buy or sell the shares suggested in this article simultaneous with, or following the release of this article. Any such transaction could affect the price of the share. All indications of performance returns are historical and cannot be relied upon as an indicator for future performance.
Share this article and show your support

Join the Conversation...

There are comments posted so far.

If you'd like to join this conversation, please login or sign up here